Does Anthem Cover Trulicity?

Anthem's Formulary Placement for Trulicity

Anthem Blue Cross Blue Shield includes Trulicity (dulaglutide) on the formulary for the majority of its commercial and employer-sponsored plans. The drug sits on Tier 3 (preferred brand) in many standard formularies, though some employer-customized plans place it on Tier 4 (non-preferred brand), which carries a higher copay. Anthem's Medicare Advantage formularies also list dulaglutide, though tier placement and cost-sharing differ by region and plan year.

Formulary inclusion does not mean automatic dispensing. Anthem applies utilization management tools to GLP-1 receptor agonists, including Trulicity. The two most common requirements are prior authorization and step therapy. Prior authorization means your prescriber must submit clinical documentation to Anthem before the pharmacy can fill the prescription. Step therapy means Anthem may require evidence that you tried and either failed or could not tolerate a less expensive first-line agent, most often metformin 1.

The American Diabetes Association's 2024 Standards of Care recommend metformin as initial pharmacotherapy for most adults with type 2 diabetes, with GLP-1 receptor agonists as preferred second-line agents for patients with established atherosclerotic cardiovascular disease (ASCVD) or at high cardiovascular risk 2. Anthem's step therapy criteria broadly mirror this guideline hierarchy.

What Trulicity Costs with Anthem Insurance

Your out-of-pocket cost depends on three variables: your plan's tier structure, your deductible status, and whether you apply a copay assistance program. On a typical Anthem Tier 3 preferred-brand plan, monthly copays for Trulicity fall between $35 and $90 after the deductible is met. Tier 4 non-preferred plans can push that number to $100 to $150 per month.

Before your annual deductible is satisfied, you may pay the full negotiated rate. That figure varies by plan but often lands between $400 and $800 for a 30-day supply, significantly below the $1,067 list price because of Anthem's negotiated pharmacy benefit discounts. Patients in high-deductible health plans (HDHPs) feel this cost most acutely in January and February each year.

Eli Lilly offers the Trulicity Savings Card, which can reduce commercially insured patients' copay to as little as $25 per month, with a maximum annual benefit. This card cannot be used with Medicare, Medicaid, or other federal healthcare programs 3. Patients on Anthem Medicare Advantage plans may instead qualify for Lilly's Patient Assistance Program or the federal Extra Help program if their income is below 150% of the poverty line.

Prior Authorization: What Anthem Requires

Anthem's prior authorization criteria for Trulicity are straightforward but must be documented precisely. The prescriber typically needs to confirm three things: a diagnosis of type 2 diabetes (ICD-10 code E11.x), a record of metformin use (or a documented contraindication such as eGFR <30 mL/min/1.73 m² or gastrointestinal intolerance), and a recent HbA1c value showing inadequate glycemic control (generally HbA1c ≥7.0%).

Turnaround time for a standard prior authorization through Anthem is 5 to 10 business days. Urgent requests, which apply when a patient is at medical risk from delayed treatment, must be processed within 72 hours under federal and most state regulations. If the initial request is denied, Anthem must provide a written explanation and instructions for appeal.

A 2023 survey by the American Medical Association found that 94% of physicians reported care delays associated with prior authorization, and 33% reported serious adverse events related to those delays 4. For patients transitioning from another GLP-1 agonist to Trulicity (for example, switching from semaglutide due to supply constraints), provide the insurer with documentation of the prior GLP-1 use to expedite review.

Dr. Robert Gabbay, Chief Scientific and Medical Officer at the American Diabetes Association, has stated: "Prior authorization creates real barriers for people with diabetes who need timely access to medications that can prevent complications. These delays can result in prolonged hyperglycemia that carries genuine cardiovascular and renal risk" 5.

Anthem Medicare Advantage vs. Commercial Plans

Coverage mechanics differ depending on whether your Anthem plan is a commercial (employer or marketplace) product or a Medicare Advantage plan. Commercial Anthem plans negotiate drug pricing through a pharmacy benefit manager (often IngenioRx, Anthem's own PBM). Medicare Advantage plans follow the Medicare Part D formulary framework, which organizes drugs into standardized tiers and applies coverage phases: deductible, initial coverage, coverage gap, and catastrophic coverage.

Under Medicare Part D in 2025, the Inflation Reduction Act capped total annual out-of-pocket prescription drug spending at $2,000 6. This means Anthem Medicare Advantage enrollees will pay no more than $2,000 per year in combined drug costs, regardless of how many medications they take. For a patient whose only specialty medication is Trulicity, monthly costs effectively drop to zero after hitting that cap.

Anthem Medicare Advantage plans also participate in the Coverage Gap Discount Program, where Eli Lilly provides a manufacturer discount during the "donut hole" phase. The practical result: even in the coverage gap, Medicare patients pay a fraction of the list price for Trulicity. Check your specific plan's Evidence of Coverage (EOC) document, available on Anthem's member portal, for exact tier and copay details.

How Trulicity Compares to Other Covered GLP-1 Options on Anthem

Anthem formularies typically include several GLP-1 receptor agonists, and their relative tier placement affects your cost. Ozempic (semaglutide 0.5 mg, 1 mg, 2 mg) often sits on the same tier as Trulicity, though some Anthem plans prefer one over the other based on rebate negotiations with manufacturers. Rybelsus (oral semaglutide) may appear on a different tier because of its distinct formulation. Mounjaro (tirzepatide), a dual GIP/GLP-1 agonist, is frequently placed on a higher (more expensive) tier or requires additional prior authorization criteria.

From an efficacy standpoint, the AWARD-11 trial (N=1,842) showed that dulaglutide 4.5 mg reduced HbA1c by 1.87% from baseline at 36 weeks, compared to 1.54% for dulaglutide 1.5 mg 7. The SUSTAIN-7 trial (N=1,201) directly compared dulaglutide 1.5 mg to semaglutide 0.5 mg and 1.0 mg, finding that semaglutide 1.0 mg produced greater HbA1c reduction (1.8% vs. 1.4%) and greater weight loss (6.5 kg vs. 3.0 kg) at 40 weeks 8.

If Anthem covers both Trulicity and Ozempic at similar copays, the choice often depends on clinical factors: injection frequency preference (both are weekly), dose flexibility, cardiovascular risk profile, and gastrointestinal tolerability. The REWIND trial (N=9,901) demonstrated that dulaglutide 1.5 mg reduced the composite endpoint of major adverse cardiovascular events (MACE) by 12% compared to placebo over a median 5.4 years in patients with type 2 diabetes, including those without prior cardiovascular events 9.

What to Do If Anthem Denies Trulicity Coverage

A denial is not the end of the process. Anthem members have the right to appeal, and success rates on appeal for GLP-1 receptor agonists are meaningful when clinical documentation is strong. The appeals process typically involves three levels.

Internal Appeal (Level 1). Your prescriber submits a letter of medical necessity with supporting lab values (HbA1c, fasting glucose), a medication history showing metformin trial or contraindication, and relevant comorbidities (ASCVD, chronic kidney disease, heart failure). Reference guideline recommendations directly. The ADA Standards of Care recommend GLP-1 receptor agonists as preferred add-on therapy for patients with ASCVD or high cardiovascular risk, independent of HbA1c 2.

External Review (Level 2). If the internal appeal fails, you can request an independent external review through your state's insurance department. An independent physician reviewer examines the case.

State Insurance Commissioner Complaint. If external review is unsuccessful, filing a formal complaint with your state's Department of Insurance can sometimes prompt re-evaluation, especially if the denial appears inconsistent with Anthem's published formulary criteria.

Dr. Irl Hirsch, Professor of Medicine at the University of Washington, has noted: "When insurers deny GLP-1 agonist coverage for patients who genuinely meet guideline criteria, clinicians should not accept the first denial. The appeal process exists precisely for these situations, and documentation quality is what wins appeals" 10.

During the appeals process, ask your prescriber about bridge supply options. Lilly's Patient Assistance Program provides free Trulicity to qualifying uninsured or underinsured patients. Some Anthem plans also allow a one-time emergency fill while the prior authorization is pending.

Anthem Coverage for Trulicity Off-Label Uses

Trulicity is FDA-approved specifically for type 2 diabetes mellitus and for reduction of major adverse cardiovascular events in adults with type 2 diabetes and established or multiple risk factors for cardiovascular disease 3. It is not approved for weight management alone, prediabetes, or type 1 diabetes.

Anthem generally does not cover Trulicity for off-label weight loss. If a prescription is written with an ICD-10 code for obesity (E66.x) rather than type 2 diabetes (E11.x), expect a denial. Some clinicians prescribe Trulicity off-label for patients with both obesity and prediabetes who have not responded to lifestyle intervention. Anthem may consider coverage in such cases only with a detailed peer-to-peer review and strong clinical justification.

The SURPASS-CVOT trial and other ongoing cardiovascular outcome studies may expand labeled indications for GLP-1 and dual-agonist drugs in coming years, which could shift insurer coverage policies 11. For now, the safest route to Anthem approval remains an on-label type 2 diabetes diagnosis with documented metformin failure or intolerance.

How to Check Your Specific Anthem Plan's Trulicity Coverage

Every Anthem plan is different. Large employers customize formularies, and marketplace plans vary by metal tier (Bronze, Silver, Gold, Platinum). Three steps will give you a definitive answer.

Step 1: Log in to Anthem's member portal. Manage to the pharmacy or drug coverage section and search for "dulaglutide" or "Trulicity." The result will show your plan's tier, estimated copay, and any utilization management requirements.

Step 2: Call the number on your Anthem ID card. Ask the pharmacy benefits representative specifically: "Is dulaglutide covered on my formulary, what tier is it on, and does it require prior authorization or step therapy?" Get the representative's name and a reference number for the call.

Step 3: Ask your pharmacist to run a test claim. A pharmacy can submit a test adjudication to Anthem's system, which returns real-time information about coverage, copay amount, and any blocks (prior authorization needed, quantity limits, step therapy edits). This is the most reliable method because it reflects your exact benefit design as of today.

Anthem updates formularies quarterly, and mid-year changes can occur with 30 to 60 days' notice. A drug that was Tier 3 in January may shift to Tier 4 in July. Always verify coverage before each refill cycle if your costs suddenly change.